ReviewThe use and resistance to antibiotics in the community
Introduction
Antibiotics are given to humans and animals for therapy and prophylaxis of infectious diseases. They are also used in animals for growth promotion and, to a lesser extent, in agriculture for plant protection and in industry [1]. In humans, 80–90% of antimicrobial drugs are used in outpatients and the rest in the hospitals [1], [2], [3], [4]. It is estimated that 20–50% of all antibiotic use is questionable [1]. The consequences of antibiotic overuse and misuse include increased risk of adverse side effects, higher cost and higher rate of antimicrobial resistance of community pathogens. What distinguishes antimicrobial agents from other drugs, is that each antimicrobial agent used may have potential significant effect on, the world microbial ecology. Antibiotics affect both pathogens and the normal flora. In theory any antibiotic can select resistant strains as long as the local concentration of the drug exceeds the minimal inhibitory concentration (MIC) for the susceptible bacterial population but is below the MIC for the resistant clone. To what extent disturbances occur depends on the spectrum of the agent, dose, route of administration, pharmacokinetic and pharmacodynamic properties, and in vivo inactivation of the agent [5]. Incomplete absorption of orally administered drugs may influence the intestinal microflora, and secretion of an antimicrobial agent by the intestinal or vaginal mucosa, bile, salivary glands or eccrine or apocrine sweat glands may interfere with the normal flora at different habitats. As a consequence, antibiotic-resistant microorganisms may increase in numbers, and they also might serve as reservoirs for resistance genes. One antibiotic may select for resistance to one or more structurally unrelated antibiotics, because resistance may be genetically linked (via co-selection of multi-resistance plasmids and other resistance traits) [6]. Some antimicrobial agents are more selective for resistance than others [7]. Besides selective antibiotic pressure, transferable resistance (clonal spread or horizontal resistance gene transfer) is the major determinant of resistance development [8]. There are several ways to study the relationship between antibiotic usage and the incidence of bacterial resistance. Pharmacoepidemiology, mathematical modelling, pharmacokinetic and microbiological analysis of several body sites that normally harbour dense microbial flora are the methods used to study the evaluation and prediction of the ecological impact of antibiotics on the human microflora, as well as the use and the effects of drugs in human populations [9].
It is irrefutable that antibiotic use promotes resistance development. However, quantifying the specific contribution of antibiotic use to resistance poses some problems. Evidence is accumulating that social, economic and genetic factors also have impact on the establishment, maintenance and spread of resistance traits.
The likelihood of selecting resistance in the community depends on many factors. The key factors are shown in Table 1.
Section snippets
Total antimicrobial usage
Antibiotic usage and resistance rates vary from one country to another [2], [3], [4]. Cars et al. found that in 1997 the non-hospital usage of antibiotics between European Union countries varied more than fourfold (Table 2) [4].
Countries with the highest per capita antibiotic consumption have the highest resistance rates (Table 2). Table 2 indicates that in countries with the total outpatient antibiotic sales beyond 25 defined daily doses (DDD)/1000 inhabitants/day, the average resistance level
Class and group of antibiotics used
A study by Baquero et al. was one of the first to report a correlation between antibiotic use and bacterial resistance in the community [31]. The emergence of penicillin-resistant S. pneumoniae (PRSP) was linked to increased use of aminopenicillins in different geographical areas in Spain [31]. The lowest rates of PRSP occurred in countries with very low rates of β-lactam prescriptions [32] (Table 3).
In contrast, consumption is highest in Spain and France where penicillin resistance is also
Reversal of resistance
The first intervention to decrease bacterial resistance in the community occurred in Japan where decreased erythromycin consumption led to a decreased level of erythromycin-resistant S. pyogenes in the 1970s [68]. In Japan, 62% of S. pyogenes isolates were resistant to erythromycin in 1974, and macrolides accounted for 22% of all antibiotics used. By 1988, macrolides accounted for only 8% of antibiotic use and the proportion of S. pyogenes isolates resistant to erythromycin fell to 2%. Because
Dosage regimens
Using antibiotics with poor activity or administering them at an inappropriate dosing level, dosing frequency, or for a prolonged duration increases the opportunity for selection of resistant strains. Guillemot et al. found that children treated with low daily doses of an oral β-lactam had an increased risk of PRSP carriage compared with children who did not [73]. Prolonged treatment (>5 days) with a β-lactam was associated with increased risk of PRSP carriage. The study by Nasrin et al. also
Pharmacokinetics/pharmacodynamics
The pharmacokinetic and pharmacodynamic properties of antibacterial agents also influence the development of resistance both in the pathogen under therapy and in the normal flora in the gut and elsewhere. Pharmacokinetic/pharmacodynamic parameters have been correlated with the drug's ability to prevent the emergence of resistant organisms. Several animal and in vitro studies have suggested that peak/MIC values of 8–10 or higher, and 24-h AUC/MIC ratios of 100 or greater can significantly reduce
Cross-infections
Organisms can spread from person to person and between humans, animals, plants and other environments or by wide spread transfer of genetic material from the initial organisms to others [85]. Resistant strains vary in their propensity for spread according to the route of transmission of the species. Resistant strains of Salmonella typhi and Shigella dysenteriae, both widespread in many developing countries, pose little risk of widespread dissemination in developed countries provided that
Patient compliance and public behaviour
Compliance is influenced by a number of factors. Many patients stop taking their medication once their symptoms have resolved yet before bacterial eradication is complete. This can lead to reinfection and selection of resistant strains. In the second type of noncompliance the patient reduces the number of daily doses. Missing one dose leads inevitably to lower serum/tissue area under the curve, and to shorter time of antibiotic concentrations over the MIC during the corresponding period. Such
Conclusion
Antimicrobial agents were introduced into medical practice almost 60 years ago. Since then, the prevalence of antimicrobial resistance in community-acquired pathogens has increased worldwide. There is a complex relationship between the consumption of antimicrobial agents and the prevalence of drug resistance. Selective antibiotic pressure and spread of resistance both by spread of resistant bacteria, as well as by resistance genes transferred between bacteria are the major determinants of
Acknowledgments
I would like to thank Bojana Beovic and Marko Pokorn for his critical review and for his helping of the preparation of manuscript. I thank Andreja Sorman for her skilful technical assistance.
References (96)
- et al.
Variation in antibiotic use in European Union
Lancet
(2001) - et al.
Effect of antimicrobial agents on the ecological balance of human microflora
Lancet Infect. Dis.
(2001) Antibiotic resistance
Med. Clin. N. Am.
(2000)- et al.
The evaluation and prediction of the ecologic impact of antibiotics in human phase I and II trial
Clin. Microbiol. Infect.
(2001) - et al.
The usage of antibiotics in Russia and some countries in Eastern Europe
Int. J. Antimicrob. Agents
(2001) - et al.
Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium update (1994–1998)
Clin. Microbiol. Infect.
(2000) - et al.
Antibiotic sensitivity still prevails in Norweigan blood culture isolates
Int. J. Antimicrob. Agents
(2001) - et al.
Antimicrobial susceptibility of nasopharyngeal isolates of Haemophilus influenzae from healthy children in day-care centres: results of multicentre study in Russia
Internat J. Antimicrob. Agents
(2001) - et al.
Change of pneumococcal resistance to antibiotics in adults between 1995 and 1997: a study in eight French counties
Int. J. Antimicrob. Agents
(2002) - et al.
Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction
Lancet
(2001)
Reasons for the emergence of antibiotic resistance
Am. J. Med. Sci.
Antimicrobal resistance is a major threat to public health
Br. Med. J.
Control of antibiotic use in the community: the Danish experience
Infect. Control Hosp. Epidemiol.
Non-hospital consumption of antibiotics in Spain: 1987–1997
J. Antimicrob. Chemother.
The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project
J. Antimicrob. Chemother.
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997–1998
J. Antimicrob. Chemother.
Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998–1999) multicenter surveillance study in Spain
Antimicrob. Agents Chemother.
Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents
Clin. Infect. Dis.
Influence of prescription patterns in general practice on antimicrobial resistance in Norway
Br. J. Gen. Pract.
Major change in the use of antibiotics following a national programme: Swedish strategic programme for the rational use of antimicrobial agents and surveillance of resistance (STRAMA)
Scand. J. Infect. Dis.
Prevalence of and detection of resistance to ampicillin and other β-lactam antibiotics in Haemophilus influenzae in Denmark
Scand. J. Infect. Dis.
Antimicrobial resistance of Streptococcus pneumoniae isolated from healthy children in day-care centers: results of a multicenter study in Russia
Pediatr. Infect. Dis. J.
Antibiotic resistance: consequences of inaction
Clin. Infect. Dis.
Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing
J. Antimicrob. Chemother.
A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe
J. Antimicrob. Chemother.
Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study
J. Antimicrob. Chemother.
A European study on the relationship between antimicrobial use and antimicrobial resistance
Emerg. Infect. Dis.
Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae
J. Clin. Microbiol.
Development of β-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978–1993
Clin. Infect. Dis.
Effect of β lactam antibiotic use in children on pneumococcal resistance to penicillin prospective cohort study
Brit. Med. J.
Effects of amoxicillin/clavulanate or azythromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media
Clin. Infect. Dis.
Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in children with respiratory tract infection
Clin. Infect. Dis.
Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae
Clin. Infect. Dis.
Do antimicrobial increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
Brit. Med. J.
Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children
Eur. J. Clin. Microbiol. Infect. Dis.
Resistance to erythromycin in group A streptococci
N. Engl. J. Med.
Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain
Eur. J. Clin. Microbiol. Infect. Dis.
Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens
Eur. J. Clin. Microbiol. Infect. Dis.
The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens
J. Antimicrob. Chemother.
Cited by (141)
In vitro and in vivo roles of cyanobacterial carbonic anhydrase as a biomarker for monitoring antibiotics
2022, Journal of Hazardous Materials LettersCitation Excerpt :For example, the long-term release of low-dose antibiotics into the environment increases the resistance of pathogenic bacteria. In addition, antibiotic resistance genes can spread and evolve in the environment, posing potential threats to ecology and human health (Cizman, 2003; Korostynska et al., 2016). Although traditional monitoring methods for antibiotics, such as high-performance liquid chromatography and mass spectrometry, can qualitatively and quantitatively analyze antibiotics, these approaches have the disadvantages of requiring expensive instruments and being time-consuming.
Decentralized systems for the treatment of antimicrobial compounds released from hospital aquatic wastes
2022, Science of the Total EnvironmentCitation Excerpt :Antibiotics are often prescribed incorrectly in cases where the compounds produce no known health benefits, commonly misused in the treatment of cold and cough symptoms. Unnecessary usage of broad-spectrum antibiotics at incorrect dosages and durations as a result of poor patient adherence further contributes to excess consumption (Čižman, 2003). The total consumption of antiviral drugs in Africa is estimated to be 1085 tons/year and assuming a minimum excretion of 30%, 326 tons of antivirals were excreted into the environment.
Introduction of the antibacterial drugs norfloxacin and Ciprofloxacin into a polyoxometalate structure: Synthesis, characterization, and antibacterial activity
2020, Journal of Molecular StructureCitation Excerpt :Some structural investigations of metal compounds (including Co(II), Ni(II), and Cu(II)) of quinolones have been reported previously [26–29]. The biological properties of quinolone metal complexes that have been examined are mainly their antibacterial activity against microorganisms, their interaction with DNA and, in some cases, their potential antitumor activity [30–33]. Recently, the crystal structures of cobalt complexes of gatifloxacin [17], enrofloxacin [34], pipemidic acid [35], and norfloxacin have also been reported [36].